Haibo Li
Impact in
- Pharmacology top 2%
- Ginger and Zingiberaceae research
- Pharmacological Effects of Natural Compounds
Papers in
-
- Natural product bioactivities and synthesis 18
-
- Phytochemistry and Biological Activities 15
- Co-authors
- Xin‐Sheng Yao (20 shared papers)Yang Yu (26 shared papers)Wei Xiao (7 shared papers)Dabo Pan (11 shared papers)Xixiang Ying (3 shared papers)Zhenzhong Wang (16 shared papers)Wei Xiao (10 shared papers)Xiaojun Yao (5 shared papers)
In The Last Decade
Haibo Li
55 papers receiving 928 citations
Peers
Comparison fields: 5 of 90
- Pharmacology 200
- Complementary and alternative medicine 95
- Rehabilitation 48
- Biochemistry 40
- Cancer Research 84
Countries citing papers authored by Haibo Li
This map shows the geographic impact of Haibo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Li more than expected).
Fields of papers citing papers by Haibo Li
This network shows the impact of papers produced by Haibo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Li. The network helps show where Haibo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Haibo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 111 | |
| 2 | 2012 | 73 | |
| 3 | 2005 | 60 | |
| 4 | 2021 | 58 | |
| 5 | 2014 | 48 | |
| 6 | 2007 | 48 | |
| 7 | 2018 | 45 | |
| 8 | 2023 | 39 | |
| 9 | 2021 | 36 | |
| 10 | 2022 | 26 | |
| 11 | 2015 | 24 | |
| 12 | 2013 | 21 | |
| 13 | 2020 | 21 | |
| 14 | 2021 | 20 | |
| 15 | 2018 | 20 | |
| 16 | 2009 | 16 | |
| 17 | 2015 | 16 | |
| 18 | 2020 | 16 | |
| 19 | 2024 | 13 | |
| 20 | 2018 | 13 |
About Haibo Li
Haibo Li is a scholar working on Molecular Biology, Plant Science, Pharmacology, Complementary and alternative medicine and Pharmacology, having authored 56 papers that have together received 951 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (18 papers), Phytochemistry and Biological Activities (15 papers), Pharmacological Effects of Natural Compounds (12 papers), Ginger and Zingiberaceae research (6 papers), Traditional Chinese Medicine Analysis (6 papers), Magnolia and Illicium research (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Sesquiterpenes and Asteraceae Studies (3 papers). The work is most often cited by research in Pharmacology (200 citations), Complementary and alternative medicine (95 citations), Rehabilitation (48 citations), Biochemistry (40 citations) and Cancer Research (84 citations). Haibo Li has collaborated with scholars based in China, Thailand and Czechia. Frequent co-authors include Xin‐Sheng Yao, Yang Yu, Wei Xiao, Dabo Pan, Xixiang Ying, Zhenzhong Wang, Wei Xiao, Xiaojun Yao, Yang Sun and Jianchun Li. Their work appears in journals such as Phytomedicine, RSC Advances, Fitoterapia, Biomedical Chromatography and Magnetic Resonance in Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.